Akums’ Haridwar factory receives ANVISA GMP certification for sterile manufacturing plant
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The inspection was conducted from July 22-25, 2025
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
Changhua site meets international regulatory standards for global medical applications
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
Sun Pharma gets 8 observations from USFDA for Halol facility
Subscribe To Our Newsletter & Stay Updated